Foghorn Therapeutics Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Letter Agreement between Foghorn Therapeutics Inc. and Anna Rivkin, dated July 18, 2024 (Filed With SEC on November 4, 2024)
- [Remainder of Page Intentionally Left Blank] (Filed With SEC on April 16, 2024)
- Letter Agreement between Foghorn Therapeutics Inc. and Alfonso Quints Cardama, M.D., dated August 4, 2023 (Filed With SEC on November 2, 2023)
- Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carlos Costa, dated July 15, 2022 (Filed With SEC on August 9, 2022)
- Description of Registrants Securities (Filed With SEC on March 18, 2021)
- Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated October 14 (Filed With SEC on October 19, 2020)
- Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated October 14 (Filed With SEC on October 19, 2020)
- Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated October 14, 2020 (Filed With SEC on October 19, 2020)
- Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated December 5, 2018 (Filed With SEC on October 2, 2020)
- Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated July 11, 2019 (Filed With SEC on October 2, 2020)
- Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated April 20, 2017 (Filed With SEC on October 2, 2020)
